Afatinib D4
| Product Name | Afatinib D4 |
|---|---|
| Alternate Names | Afatinib Stable Isotopes, Stable Isotopes of Afatinib |
| CAT No. | CS-O-13074 |
| CAS No. | 850140-72-6 ( Unlabeled) |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Afatinib |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | ClC1=C(F)C=CC(NC2=NC=NC3=C2C=C(NC(/C=C/CN(C)C)=O)C(O[C@H]4CC([2H])([2H])OC4([2H])[2H])=C3)=C1 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Afatinib D4 is a medication that is used in the treatment of non-small cell lung cancer in adults. It is a derivative of afatinib, which is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) family of proteins. The D4 variant of afatinib is a deuterated form of the drug, which means that it contains isotopes of hydrogen that have been replaced with deuterium. This modification can improve the pharmacokinetic properties of the drug, resulting in a longer half-life and potentially improved efficacy.
Afatinib D4 works by blocking the activity of the EGFR family of proteins, which are involved in the growth and spread of cancer cells. By inhibiting these proteins, afatinib D4 can slow down or stop the growth of cancer cells, ultimately leading to their death. It is typically used in patients who have already received other treatments for their cancer, and whose cancer has worsened or spread to other parts of the body.
In terms of chemical information, afatinib D4 has a molecular formula of C24H22D4BrFN4O3 and a molecular weight of 511.43 g/mol. It is a white to yellowish powder that is soluble in water and organic solvents. The recommended dosage of afatinib D4 can vary depending on the patient's individual condition and response to treatment, and should be determined by a qualified healthcare professional.
Get an Instant Quote
Related Compounds
Afatinib 13C6 | Afatinib D6 |